Loading the company profile
Public data, as of October 2026
Company profile
Boehringer Ingelheim Pharmaceuticals, Inc.
boehringer-ingelheim.comNo disclosure matched yet
The Data Hub has no reported emissions for this company yet, so there is no footprint to summarize.
SBTi status
No SBTi record is linked to this company yet.
Where insetting fits
Scope 3 appears once a full disclosure is matched.
Peer position
A peer comparison appears once sector peers report their emissions.
Voluntary retirements
Registry records show about 240,000 credits retired for this company.
Emissions
How the reported footprint breaks down by scope and year.
tCO₂e, GHG Protocol scopes
Peer benchmark
How Boehringer Ingelheim Pharmaceuticals, Inc. compares with its industry peers on Scope 3.
Peers are other companies in the same SBTi industry, by Scope 3 share of the latest reported footprint.
No sector peers with a reported Scope 3 share yet
A comparison needs reported Scope 1, 2 and 3 emissions for at least one other company in the same sector.
Research summary
What the public record says about this company's decarbonization.
No report has been generated for this company yet
Anyone can read a cached company report, while generating a new one can take a few minutes and needs a free account.
Related projects
Decarbonization projects that name the company as a partner.
Emerging projects catalog, status as reported by each project
Company profile
A claimed profile keeps the figures accurate and shows the company’s projects.
Claiming is free. Your team can correct data, add newer disclosures and list reduction projects from your value chain, so that customers and suppliers can co-fund them.
- 1Confirm employment at the company